Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to reflect a change in recruitment status to 'Active, not recruiting' and has new date entries for 2025, while several previous dates and contact information have been removed.
    Difference
    2%
    Check dated 2025-06-27T00:36:09.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.8%
    Check dated 2025-06-19T19:46:54.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:12:58.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:57:27.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:02.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated to include new collaborators, a revised version number, and a registry identifier for a clinical trial on rhabdomyosarcoma, while significant details about the trial's objectives and treatment methods have been removed.
    Difference
    53%
    Check dated 2025-04-16T02:06:30.000Z thumbnail image

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.